GoodRx examined the prices for 20 common specialty medications, finding that Medicare Part D enrollees had to pay more than $3,200 in 2021 for each of the drugs on that list. Revlimid and Ibrance were the most expensive drugs on the list, with Medicare Part D enrollees having to pay an annual price of $17,142 and $13,865, respectively.
There are several factors that affect the amount Medicare Part D enrollees pay for their specialty medications, including the Medicare plan a patient selects, the distinct phase of their plan and drugs’ list prices.
Different plans offer very different cost savings for specialty medications, so patients could benefit from shopping around. For example, Revlimid’s price varies from $20,013 to $2,818 across different Medicare Part D plans. Except for one, all of the 20 drugs had a difference of at least $2,000 between their maximum and minimum annual out-of-pocket costs across plans.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.